APA

Bossi M., Botti G., Campus S., Cardini A., Cherchi A., Coljca A., Di Benedetto A., Folli G., Franzosi P., Geraci E., Lampertico M., Lotto A., Magnani B., Modica G., Selvini A., Serio G. & Visioli O. (19700317). [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]. : Minerva medica.

Chicago

Bossi M, Botti G, Campus S, Cardini A, Cherchi A, Coljca A, Di Benedetto A, Folli G, Franzosi P, Geraci E, Lampertico M, Lotto A, Magnani B, Modica G, Selvini A, Serio G and Visioli O. 19700317. [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]. : Minerva medica.

Harvard

Bossi M., Botti G., Campus S., Cardini A., Cherchi A., Coljca A., Di Benedetto A., Folli G., Franzosi P., Geraci E., Lampertico M., Lotto A., Magnani B., Modica G., Selvini A., Serio G. and Visioli O. (19700317). [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]. : Minerva medica.

MLA

Bossi M, Botti G, Campus S, Cardini A, Cherchi A, Coljca A, Di Benedetto A, Folli G, Franzosi P, Geraci E, Lampertico M, Lotto A, Magnani B, Modica G, Selvini A, Serio G and Visioli O. [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]. : Minerva medica. 19700317.